Institutional investors purchased a net $90.2 thousand shares of MNOV during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 3.70% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST NEW YORK SECURITIES LLC Bought 58.5 Thousand shares of MediciNova Inc
JANE STREET CAPITAL LLC Bought 19.4 Thousand shares of MediciNova Inc